Strengthening institutional review board review of highly innovative interventions in clinical trials

JAMA

Volumn 302, Issue 24, 2009, Pages 2697-2698

  Lo, Bernard ^a,b   Grady, Deborah ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD SUBSTITUTE; IMMUNOMODULATING AGENT; MONOCLONAL ANTIBODY;

ADVISORY COMMITTEE; CLINICAL TRIAL; EXPERIMENTAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPOTENSION; INSTITUTIONAL REVIEW; MANDATORY REPORTING; METHODOLOGY; NATIONAL HEALTH ORGANIZATION; NOTE; PATIENT SAFETY; PRIORITY JOURNAL; PROTECTION; TREATMENT OUTCOME; ARTICLE; DRUG TOXICITY; ETHICS; INTERPERSONAL COMMUNICATION; PROFESSIONAL STANDARD; RISK; UNITED STATES; UNIVERSITY HOSPITAL;

ACADEMIC MEDICAL CENTERS; CLINICAL TRIALS AS TOPIC; DISCLOSURE; DRUG TOXICITY; ETHICS COMMITTEES, RESEARCH; HUMANS; NATIONAL INSTITUTES OF HEALTH (U.S.); RISK; UNITED STATES;

EID: 73949149032     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2009.1917     Document Type: Note

References (10)

1. Amariglio N, Hirshberg A, Scheithauer BW, et al. Donor-derived brain tumor following neural stem cell transplantation in an ataxia telangiectasia patient. PLoS Med. 2009;6(2):e1000029.
2. Hacein-Bey-Abina S, Von Kalle C, Schmidt M, et al. LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science. 2003; 302(5644):415-419.
3. Schneider CK, Kalinke U, Lower J. TGN1412-a regulator's perspective. Nat Biotechnol. 2006;24(5):493-496.
4. Ertl H. The RAC: double, double, toil, and trouble? Mol Ther. 2009;17(3): 397-399.
5. Scharschmidt T, Lo B. Clinical trial design issues raised during recombinant DNA advisory committee review of gene transfer protocols. Hum Gene Ther. 2006; 17(4):448-454.
6. National Cancer Institute. The Central Institutional Review Board Initiative. http://www.ncicirb.org/. Accessed March 30, 2008.
7. Lo B, Field M. Conflict of Interest in Medical Research, Education, and Practice. Washington, DC: National Academies Press; 2009:4-8.
8. Citizens for Responsible Care and Research. The Polyheme Trial Part A. http://www.circare.org/subjects/polyhemetrial.htm. Accessed August 11, 2009.
9. 6/L CD4 cell counts: a randomized controlled trial. JAMA. 2000;284(17):2193-2202.
10. Food and Drug Administration. Food and Drug Administration Amendments Act (FDAAA) of 2007. http://www.fda.gov/RegulatoryInformation/Legislation/ FederalFoodDrugandCosmeticActFDCAct/SignificantAmendmentstotheFDCAct/ FoodandDrugAdministrationAmendmentsActof2007/FullTextofFDAAALaw/default.htm. Accessed June 9, 2009.